Veru Announces Positive Phase 1b/2 Clinical Study Update for Sabizabulin (VERU-111) in Men with Metastatic Castration Resistant Prostate Cancer Presented at the 2021 ASCO Annual Meeting

NEXT STORY
Results from Novan’s Exploratory Studies Further Demonstrate Antimicrobial Effect of NITRICIL™ Platform Technology with NVN4100 in Companion Animal Health
PREV STORY
Berkshire Grey to Present at the UBS Global Industrials and Transportation Virtual Conference on June 8, 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

NANOBIOTIX : Résultats semestriels au 30 juin 2017

  Résultats semestriels au 30 juin 2017 Paris, France, et Cambridge, Massachusetts (USA) le ...

author_avatar
NASDAQ Market News

Rheumatology Leaders to HHS: Prior Authorization, Recent Part B Payment Change are Biggest Threats to Healthcare Choice and Competition

Washington, DC, Jan. 30, 2018 (GLOBE NEWSWIRE) -- In its response to the U.S. ...

author_avatar
NASDAQ Market News

XBiotech Advances to Phase II Portion of Clinical Study of Novel True Human™ Therapeutic Antibody for Treating Serious Infections Due to Staphylococcus aureus

AUSTIN, Texas, March 28, 2016 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ:XBIT), developer of True Human™ ...

author_avatar
NASDAQ Market News